| Literature DB >> 22848457 |
Wuelton Marcelo Monteiro1, Laylah Kelre Costa Magalhães, Amanda Regina Nichi de Sá, Mônica Lúcia Gomes, Max Jean de Ornelas Toledo, Lara Borges, Isa Pires, Jorge Augusto de Oliveira Guerra, Henrique Silveira, Maria das Graças Vale Barbosa.
Abstract
BACKGROUND: Chagas disease is an emergent tropical disease in the Brazilian Amazon Region, with an increasing number of cases in recent decades. In this region, the sylvatic cycle of Trypanosoma cruzi transmission, which constitutes a reservoir of parasites that might be associated with specific molecular, epidemiological and clinical traits, has been little explored. The objective of this work is to genetically characterize stocks of T. cruzi from human cases, triatomines and reservoir mammals in the State of Amazonas, in the Western Brazilian Amazon. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 22848457 PMCID: PMC3405119 DOI: 10.1371/journal.pone.0041284
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Representative polyacrylamide gel of the rRNA gene amplification for Trypanosoma cruzi isolates from humans (H), triatomines (T) and marsupials (M) from the State of Amazonas.
MM, 100 bp molecular weight marker. NC, negative control.
Figure 2Allocation of the Trypanosoma cruzi isolated in the State of Amazonas into known phylogenetic clusters, most recently classified as TcI to TcVI, based on cytochrome c oxidase subunit II gene sequencing.
Figure 3Allocation of the Trypanosoma cruzi isolated in the State of Amazonas into known phylogenetic clusters, most recently classified as TcI to TcVI, based on glucose-phosphate isomerase gene sequencing.
Figure 4Geographic distribution and reservoirs of the haplotypes of the Trypanosoma cruzi isolated in the State of Amazonas, based on single-nucleotide polymorphisms identified by cytochrome c oxidase subunit II gene sequencing.
Figure 5Geographic distribution and reservoirs of the haplotypes of the Trypanosoma cruzi isolated in the State of Amazonas, based on single-nucleotide polymorphisms identified by glucose-phosphate isomerase gene sequencing.